跳至主要内容
临床试验/ISRCTN22639386
ISRCTN22639386未知未知

Autologous bone marrow-derived cells for cardioprotection during heart surgery

niversity Hospitals of Leicester NHS Trust (UK)0 个研究点目标入组 44 人开始时间: 2007年2月14日最近更新:
适应症

试验速览

阶段
未知
发起方
入组人数
44

研究概览

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1. Triple vessel coronary artery disease with or without significant disease of the left main stem with indication of elective surgical revascularisation
  • 2. Left ventricular ejection fraction greater than 40%
  • 3. Age 20 to 80 years

排除标准

  • In addition to not being compliant to the inclusion criteria, the following criteria will be sufficient to exclude patients from entering the study:
  • 1. Cardiogenic shock (need for inotropic drugs, intra-aortic balloon pump)
  • 2. Previous Coronary Artery Bypass Graft (CABG)
  • 3. Percutaneous Coronary Infusion (PCI) in the previous three months
  • 4. History of neoplastic disease
  • 5. History of bleeding disorder
  • 6. Chronic inflammatory disease
  • 7. Active infection
  • 8. Renal impairment (creatinine more than 180 mmol/l)
  • 9. Liver dysfunction (Glutamate Oxalate Transferase [GOT] more than 2 x Upper Limit of Normal [ULN] or International Normalised Ratio [INR] more than 1.5 x ULN)
  • 10. Diabetes
  • 11. Chronic treatment with oral antibiotic agents

研究者

发起方
niversity Hospitals of Leicester NHS Trust (UK)

相似试验

Autologous bone marrow-derived cells for... | 临床试验